Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,039 | -262,140 | -311,458 | -206,356 | -135,678 |
| Depreciation Amortization | -4,302 | -5,468 | -1,319 | 3,908 | 194 |
| Accounts receivable | -47,259 | -17,349 | -8,458 | 0 | 0 |
| Accounts payable and accrued liabilities | 2,229 | 3,152 | 1,565 | 245 | 5,674 |
| Other Working Capital | -15,080 | -23,501 | -10,175 | 3,620 | 14,133 |
| Other Operating Activity | 92,293 | 58,249 | 72,130 | 23,956 | 2,644 |
| Operating Cash Flow | $-112,158 | $-247,057 | $-257,715 | $-174,627 | $-113,033 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 33,963 | 180,660 | -63,916 | -74,958 | -181,503 |
| PPE Investments | -143 | -428 | -15,783 | -995 | -321 |
| Purchase Sale Intangibles | -5,000 | N/A | -7,500 | N/A | N/A |
| Other Investing Activity | -5,000 | 0 | -7,500 | 0 | 0 |
| Investing Cash Flow | $28,820 | $180,232 | $-87,199 | $-75,953 | $-181,824 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 125,000 | 73,987 | N/A |
| Debt Repayment | -100,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 166,202 | 98,187 | 164,530 | 209,597 | 298,145 |
| Other Financing Activity | 0 | 3,136 | 12,268 | -1,637 | 0 |
| Financing Cash Flow | $66,202 | $101,323 | $301,798 | $281,947 | $298,145 |
| Exchange Rate Effect | -235 | -50 | 0 | N/A | N/A |
| Beginning Cash Position | 89,323 | 54,875 | 97,991 | 66,624 | 63,336 |
| End Cash Position | 71,952 | 89,323 | 54,875 | 97,991 | 66,624 |
| Net Cash Flow | $-17,371 | $34,448 | $-43,116 | $31,367 | $3,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -112,158 | -247,057 | -257,715 | -174,627 | -113,033 |
| Capital Expenditure | -143 | -428 | -15,783 | -995 | -321 |
| Free Cash Flow | -112,301 | -247,485 | -273,498 | -175,622 | -113,354 |